Technology
Health
Biotechnology

Vical

$0.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0241 (-3.35%) Today
+$0.0341 (4.90%) As of 4:28 PM EDT after-hours

Why Robinhood?

You can buy or sell Vical and other stocks, options, ETFs, and crypto commission-free!

About VICL

Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Read More Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.

Employees
30
Headquarters
San Diego, California
Founded
1987
Market Cap
16.45M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
254.69K
High Today
$0.74
Low Today
$0.6653
Open Price
$0.72
Volume
641.76K
52 Week High
$1.47
52 Week Low
$0.6653

Collections

Technology
Health
Biotechnology
Research And Development
Biopharmaceutical
Pharmaceutical
US
North America

VICL Earnings

-$0.29
-$0.22
-$0.14
-$0.07
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.